Over the past decade, China’s pharmaceutical industry has completed a breathtaking leap forward — compressing into ten years a journey that took the United States three to four decades. Today, we stand at a new inflection point: the global hub for innovative drug transactions is shifting from a single U.S. engine to a dual-engine structure driven by both the U.S. and China.

Global Session on Small Nucleic Acid Drug Innovation – First Speakers Revealed

May 30,2026

Small Nucleic Acid Drug Innovation Global Conference Session — co-organized by Tofflon Group, InnoStar, ChemPartner, and GemPharmatech — today announces its first group of speakers. Leading scientists, pharma executives, and clinical experts from China and abroad will gather on the same stage for conversations focused not on rhetoric, but on breakthroughs, collaboration, and the future.

USTC / China-Japan Pharmaceutical & New Materials Innovation Special Session – USTC’s Original Innovation Power: Agenda Released

May 30,2026

July 22 to 24,National Exhibition and Convention Center (Shanghai) . We hope to align with USTC’s innovative forces and jointly explore the journey of original innovation for new drug research and development.

< 1...11 12 13...26 > proceed page

Follow or Contact Us

Follow the TONACEA Official WeChat Account and scan the QR code to register. Stay updated with the latest conference news.

Public Account QR Code

Registration QR Code

Conference Service Hotline

+86 010 8363 4290

© 2026 TONACEA (Shanghai) Technology Development Co., Ltd. All rights reserved. All rights reserved.